OtherReview Articles
Posterior Reversible Encephalopathy Syndrome, Part 2: Controversies Surrounding Pathophysiology of Vasogenic Edema
W.S. Bartynski
American Journal of Neuroradiology June 2008, 29 (6) 1043-1049; DOI: https://doi.org/10.3174/ajnr.A0929

References
- ↵Dinsdale HB. Hypertensive encephalopathy. Neurol Clin 1983;1:3–16
- Schwartz RB, Bravo SM, Klufas RA, et al. Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MR findings in 16 cases. AJR Am J Roentgenol 1995;165:627–31
- ↵Schwartz RB, Jones KM, Kalina P, et al. Hypertensive encephalopathy: findings on CT, MR imaging, and SPECT imaging in 14 cases. AJR Am J Roentgenol 1992;159:379–83
- ↵Strandgaard S, Olesen J, Skinhoj E, et al. Autoregulation of brain circulation in severe arterial hypertension. BMJ 1973;1:507–10
- ↵Guyton AC. Cerebral blood flow, cerebrospinal fluid and brain metabolism. In: Gutyton AC, ed. Textbook of Medical Physiology. 11th ed. Philadelphia: Elsevier Saunders;2006 :761–68
- ↵Zwienenberg-Lee M, Muizelaar JP. Clinical pathophysiology of traumatic brain injury. In: HR W, ed. Youmans Neurological Surgery. 5th ed. Philadelphia: Saunders;2004 :5039–64
- ↵Langfitt TW, Obrist WD. Occlusive cerebrovascular disease. In: Wilkins RH, Rengachary SS, eds. Neurosurgery. New York: McGraw-Hill;1985 :1167–73
- ↵Auer LM. The pathogenesis of hypertensive encephalopathy: experimental data and their clinical relevance with special reference to neurosurgical patients. Acta Neurochir Suppl (Wien) 1978;27:1–111
- ↵Kontos HA, Wei EP, Navari RM, et al. Responses of cerebral arteries and arterioles to acute hypotension and hypertension. Am J Physiol 1978;234:H371–83
- ↵MacKenzie ET, Strandgaard S, Graham DI, et al. Effects of acutely induced hypertension in cats on pial arteriolar caliber, local cerebral blood flow, and the blood-brain barrier. Circ Res 1976;39:33–41
- ↵Kalimo H, Kaste M, Haltia M. Vascular diseases. In: Graham DI, Lantos PL, eds. Greenfield's Neuropathology. 7th ed. New York: Oxford University Press;2002 :281–356
- ↵Kaplan NM. Management of hypertensive emergencies. Lancet 1994;344:1335–38
- ↵Servillo G, Bifulco F, De Robertis E, et al. Posterior reversible encephalopathy syndrome in intensive care medicine. Intensive Care Med 2007;33:230–36
- ↵Striano P, Striano S, Tortora F, et al. Clinical spectrum and critical care management of posterior reversible encephalopathy syndrome (PRES). Med Sci Monit 2005;11:CR549–53
- ↵Kwon S, Koo J, Lee S. Clinical spectrum of reversible posterior leukoencephalopathy syndrome. Pediatr Neurol 2001;24:361–64
- Rail DL, Perkin GD. Computerized tomographic appearance of hypertensive encephalopathy. Arch Neurol 1980;37:310–11
- Weingarten K, Barbut D, Filippi C, et al. Acute hypertensive encephalopathy: findings on spin-echo and gradient-echo MR imaging. AJR Am J Roentgenol 1994;162:665–70
- ↵Weingarten KL, Zimmerman RD, Pinto RS, et al. Computed tomographic changes of hypertensive encephalopathy. AJNR Am J Neuroradiol 1985;6:395–98
- ↵Apollon KM, Robinson JN, Schwartz RB, et al. Cortical blindness in severe preeclampsia: computed tomography, magnetic resonance imaging, and single-photon-emission computed tomography findings. Obstet Gynecol 2000;95:1017–19
- ↵Bartynski WS, Boardman JF. Distinct imaging patterns and lesion distribution in posterior reversible encephalopathy syndrome (PRES). AJNR Am J Neuroradiol 2007;28:1320–27
- ↵Bartynski WS, Zeigler Z, Spearman MP, et al. Etiology of cortical and white matter lesions in cyclosporin-A and FK-506 neurotoxicity. AJNR Am J Neuroradiol 2001;22:1901–14
- ↵Sibai BM. Eclampsia. VI. Maternal-perinatal outcome in 254 consecutive cases. Am J Obstet Gynecol 1990;163:1049–54, discussion 1054–55
- ↵Bartynski WS. Posterior reversible encephalopathy syndrome, part 1: fundamental imaging and clinical features. AJNR Am J Neuroradiol 2008 Mar 20 [Epub ahead of print]
- ↵Bartynski WS, Boardman JF. Catheter angiography, MR angiography and MR perfusion in posterior reversible encephalopathy syndrome. AJNR Am J Neuroradiol. 2008;29:447–55
- ↵Bartynski WS, Zeigler ZR, Shadduck RK, et al. Pretransplantation conditioning influence on the occurrence of cyclosporine or FK-506 neurotoxicity in allogeneic bone marrow transplantation. AJNR Am J Neuroradiol 2004;25:261–69
- ↵Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:494–500
- Mukherjee P, McKinstry RC. Reversible posterior leukoencephalopathy syndrome: evaluation with diffusion-tensor MR imaging. Radiology 2001;219:756–65
- ↵Reece DE, Frei-Lahr DA, Shepherd JD, et al. Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin. Bone Marrow Transplant 1991;8:393–401
- ↵Mark AL. Cyclosporine, sympathetic activity, and hypertension. N Engl J Med 1990;323:748–50
- ↵Scherrer U, Vissing SF, Morgan BJ, et al. Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med 1990;323:693–99
- ↵Brubaker LM, Smith JK, Lee YZ, et al. Hemodynamic and permeability changes in posterior reversible encephalopathy syndrome measured by dynamic susceptibility perfusion-weighted MR imaging. AJNR Am J Neuroradiol 2005;26:825–30
- ↵Engelter ST, Petrella JR, Alberts MJ, et al. Assessment of cerebral microcirculation in a patient with hypertensive encephalopathy using MR perfusion imaging. AJR Am J Roentgenol 1999;173:1491–93
- ↵Naidu K, Moodley J, Corr P, et al. Single photon emission and cerebral computerised tomographic scan and transcranial Doppler sonographic findings in eclampsia. Br J Obstet Gynaecol 1997;104:1165–72
- ↵Camargo EE. Brain SPECT in neurology and psychiatry. J Nucl Med 2001;42:611–23
- ↵Hypertensive disorders of pregnancy. In: Cunningham FG, Gant NF, Leveno KJ, et al, eds. Williams Obstetrics. 21st ed. New York: McGraw Hill;2001 :567–618
- ↵Dekker GA, Sibai BM. Etiology and pathogenesis of preeclampsia: current concepts. Am J Obstet Gynecol 1998;179:1359–75
- ↵Bartynski WS, Boardman JF, Zeigler ZR, et al. Posterior reversible encephalopathy syndrome in infection, sepsis, and shock. AJNR Am J Neuroradiol 2006;27:2179–90
- ↵Bartynski WS, Tan HP, Boardman JF, et al. Posterior reversible encephalopathy syndrome after solid organ transplantation. AJNR Am J Neuroradiol 2008;29:924–30
- ↵Coughlin WF, McMurdo SK, Reeves T. MR imaging of postpartum cortical blindness. J Comput Assist Tomogr 1989;13:572–76
- ↵Trommer BL, Homer D, Mikhael MA. Cerebral vasospasm and eclampsia. Stroke 1988;19:326–29
- ↵Toole JF. Lacunar syndromes and hypertensive encephalopathy. In: Toole JF, ed. Cerebrovascular Disorders. 5th ed. New York: Raven;1999 :342–55
- ↵Shimono T, Miki Y, Toyoda H, et al. MR imaging with quantitative diffusion mapping of tacrolimus-induced neurotoxicity in organ transplant patients. Eur Radiol 2003;13:986–93
- ↵Maemura K, Kurihara H, Morita T, et al. Production of endothelin-1 in vascular endothelial cells is regulated by factors associated with vascular injury. Gerontology 1992;38(suppl 1):29–35
- Mantovani A, Bussolino F, Dejana E. Cytokine regulation of endothelial cell function. FASEB J 1992;6:2591–99
- ↵Marsden PA, Brenner BM. Transcriptional regulation of the endothelin-1 gene by TNF-alpha. Am J Physiol 1992;262:C854–61
- ↵Geraghty JJ, Hoch DB, Robert ME, et al. Fatal puerperal cerebral vasospasm and stroke in a young woman. Neurology 1991;41:1145–47
- ↵Lewis LK, Hinshaw DB Jr, Will AD, et al. CT and angiographic correlation of severe neurological disease in toxemia of pregnancy. Neuroradiology 1988;30:59–64
- ↵Belfort MA, Saade GR, Grunewald C, et al. Association of cerebral perfusion pressure with headache in women with pre-eclampsia. Br J Obstet Gynaecol 1999;106:814–21
- Qureshi AI, Frankel MR, Ottenlips JR, et al. Cerebral hemodynamics in preeclampsia and eclampsia. Arch Neurol 1996;53:1226–31
- ↵Williams KP, Wilson S. Persistence of cerebral hemodynamic changes in patients with eclampsia: a report of three cases. Am J Obstet Gynecol 1999;181:1162–65
- ↵The placenta and fetal membranes. In: Cunningham FG, Gant NF, Leveno KJ, Gilstrap LC, Hauth JC, Wenstrom KD, eds. Williams Obstetrics. 21st ed. New York: McGraw Hill;2001 :85–108
- ↵Hill GR, Crawford JM, Cooke KR, et al. Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines. Blood 1997;90:3204–13
- ↵Antin JH, Ferrara JL. Cytokine dysregulation and acute graft-versus-host disease. Blood 1992;80:2964–68
- ↵
- Holler E, Kolb HJ, Moller A, et al. Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. Blood 1990;75:1011–16
- ↵
- ↵Zeigler ZR, Rosenfeld CS, Andrews DF 3rd, et al. Plasma von Willebrand factor antigen (vWF:AG) and thrombomodulin (TM) levels in adult thrombotic thrombocytopenic purpura/hemolytic uremic syndromes (TTP/HUS) and bone marrow transplant-associated thrombotic microangiopathy (BMT-TM). Am J Hematol 1996;53:213–20
- ↵Ramanathan V, Helderman JH. Cyclosporine formulations. In: Sayegh M, Remuzzi G, eds. Current and Future Immunosuppressive Therapies Following Transplantation. The Netherlands: Kluwer Academic;2001 :111–21
- ↵Shapiro R. Tacrolimus. In: Sayegh M, Remuzzi G, eds. Current and Future Immunosuppressive Therapies Following Transplantation. The Netherlands: Kluwer Academic;2001 :123–42
- ↵Holler E, Kolb HJ, Hiller E, et al. Microangiopathy in patients on cyclosporine prophylaxis who developed acute graft-versus-host disease after HLA-identical bone marrow transplantation. Blood 1989;73:2018–24
- ↵Kon V, Sugiura M, Inagami T, et al. Role of endothelin in cyclosporine-induced glomerular dysfunction. Kidney Int 1990;37:1487–91
- ↵Rouquette-Gally AM, Boyeldieu D, Gluckman E, et al. Autoimmunity in 28 patients after allogeneic bone marrow transplantation: comparison with Sjogren syndrome and scleroderma. Br J Haematol 1987;66:45–47
- ↵Munford RS. Sepsis, severe sepsis and septic shock. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Disease. Philadelphia: Elsevier;2005 :906–26
- Varon J, Marik PE. Multiple organ dysfunction syndrome. In: Irwin RS, Rippe JM, eds. Irwin and Rippe's Intensive Care Medicine. 5th ed. Philadelphia: Lippincott-Williams & Wilkins;2003 :1834–38
- ↵Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure: on behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996;22:707–10
- ↵Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448–54
- ↵
- ↵Aird WC. The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood 2003;101:3765–77
- Mutunga M, Fulton B, Bullock R, et al. Circulating endothelial cells in patients with septic shock. Am J Respir Crit Care Med 2001;163:195–200
- ↵Parent C, Eichacker PQ. Neutrophil and endothelial cell interactions in sepsis: the role of adhesion molecules. Infect Dis Clin North Am 1999;13:427–47, x
- ↵McCuskey RS, Urbaschek R, Urbaschek B. The microcirculation during endotoxemia. Cardiovasc Res 1996;32:752–63
- ↵Symeonides S, Balk RA. Nitric oxide in the pathogenesis of sepsis. Infect Dis Clin North Am 1999;13:449–63, x
- ↵Sands KE, Bates DW, Lanken PN, et al. Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA 1997;278:234–40
- ↵Wanecek M, Weitzberg E, Rudehill A, et al. The endothelin system in septic and endotoxin shock. Eur J Pharmacol 2000;407:1–15
- ↵Sugiura M, Inagami T, Kon V. Endotoxin stimulates endothelin-release in vivo and in vitro as determined by radioimmunoassay. Biochem Biophys Res Commun 1989;161:1220–27
- ↵Bannan J, Visvanathan K, Zabriskie JB. Structure and function of streptococcal and staphylococcal superantigens in septic shock. Infect Dis Clin North Am 1999;13:387–96, ix
- ↵Kotb M. Bacterial pyrogenic exotoxins as superantigens. Clin Microbiol Rev 1995;8:411–26
- ↵Sriskandan S, Cohen J. Gram-positive sepsis: mechanisms and differences from gram-negative sepsis. Infect Dis Clin North Am 1999;13:397–412
- ↵Halloran PF, Batiuk TD, Goes N, et al. Immunologic concepts. In: Stuart FP, Abecassis MM, DB K, eds. Organ Transplantation. 2nd ed. Georgetown, Tex: Landes Bioscience;2003 :1–44
- ↵Cerilli J, Brasile L, Galouzis T, et al. The vascular endothelial cell antigen system. Transplantation 1985;39:286–89
- ↵Immunity to tumors. In: Abbas AK, Lichtman AH, eds. Cellular and Molecular Immunology 5th ed. Philadelphia: Elsevier Saunders;2005;391–410
- ↵Starzl TE, Demetris AJ, Trucco M, et al. Cell migration, chimerism, and graft acceptance, with particular reference to the liver. In: Busuttil RW, Klintmalm G, eds. Transplantation of the Liver. Philadelphia: WB Saunders;1996 :274–87
- ↵Bianchi DW, Zickwolf GK, Weil GJ, et al. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci U S A 1996;93:705–08
- ↵Thomas MR, Williamson R, Craft I, et al. Y chromosome sequence DNA amplified from peripheral blood of women in early pregnancy. Lancet 1994;343:413–14
- ↵Holzgreve W, Ghezzi F, Di Naro E, et al. Disturbed feto-maternal cell traffic in preeclampsia. Obstet Gynecol 1998;91:669–72
- ↵Smith A. Systemic sclerosis: etiology and pathogenesis. In: Hochbert MC, Silman AJ, Smolen JS, et al, eds. Rheumatology. 3rd ed. Edinburgh, UK: Mosby;2003 :1481–92
- ↵Artlett CM, Smith JB, Jimenez SA. Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. N Engl J Med 1998;338:1186–91
- ↵Nelson JL, Furst DE, Maloney S, et al. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 1998;351:559–62
- ↵Furst DE, Clements PJ, Graze P, et al. A syndrome resembling progressive systemic sclerosis after bone marrow transplantation: a model for scleroderma? Arthritis Rheum 1979;22:904–10
- ↵McCormick LL, Zhang Y, Tootell E, et al. Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma. J Immunol 1999;163:5693–99
- ↵Crow MK. Cellular immunity: systemic lupus erythematosus. In: Hochbert MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH, eds. Rheumatology. 3rd ed. Edinburgh, UK: Mosby;2003 :1347–58
- ↵Stone JH, Hoffman GS. Wegener's granulomatosis and lymphomatoid granulomatosis. In: Hochbert MC, Silman AJ, Smolen JS, et al, eds. Rheumatology. 3rd ed. Edinburgh, UK: Mosby;2003 :1624–34
- ↵Ito T, Sakai T, Inagawa S, et al. MR angiography of cerebral vasospasm in preeclampsia. AJNR Am J Neuroradiol 1995;16:1344–46
- Lin JT, Wang SJ, Fuh JL, et al. Prolonged reversible vasospasm in cyclosporin A-induced encephalopathy. AJNR Am J Neuroradiol 2003;24:102–04
- ↵
- ↵
- ↵Kevil CG, Payne DK, Mire E, et al. Vascular permeability factor/vascular endothelial cell growth factor-mediated permeability occurs through disorganization of endothelial junctional proteins. J Biol Chem 1998;273:15099–103
- Levy AP, Levy NS, Wegner S, et al. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J Biol Chem 1995;270:13333–40
- ↵Shweiki D, Itin A, Soffer D, et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992;359:843–45
- ↵Chavez JC, Agani F, Pichiule P, et al. Expression of hypoxia-inducible factor-1 alpha in the brain of rats during chronic hypoxia. J Appl Physiol 2000;89:1937–42
- ↵Schoch HJ, Fischer S, Marti HH. Hypoxia-induced vascular endothelial growth factor expression causes vascular leakage in the brain. Brain 2002;125:2549–57
- ↵Sengar AR, Gupta RK, Dhanuka AK, et al. MR imaging, MR angiography, and MR spectroscopy of the brain in eclampsia. AJNR Am J Neuroradiol 1997;18:1485–90
- ↵Xu L, Fukumura D, Jain RK. Acidic extracellular pH induces vascular endothelial growth factor (VEGF) in human glioblastoma cells via ERK1/2 MAPK signaling pathway: mechanism of low pH-induced VEGF. J Biol Chem 2002;277:11368–74. Epub 2001 Dec 11
- ↵Weinberger MH. Hypertensive encephalopathy. In: Noseworthy JH, ed. Neurological Therapeutics: Principles and Practice. 2nd ed. Milton Park, Abington, Oxon, UK: Informa Healthcare;2006 :670–73
- ↵Thompson CB, June CH, Sullivan KM, et al. Association between cyclosporin neurotoxicity and hypomagnesaemia. Lancet 1984;2:1116–20
- ↵van den Bergh WM, Algra A, van Kooten F, et al. Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke 2005;36:1011–15
- Belfort MA, Moise KJ Jr. Effect of magnesium sulfate on maternal brain blood flow in preeclampsia: a randomized, placebo-controlled study. Am J Obstet Gynecol 1992;167:661–66
- ↵Ram Z, Sadeh M, Shacked I, et al. Magnesium sulfate reverses experimental delayed cerebral vasospasm after subarachnoid hemorrhage in rats. Stroke 1991;22:922–27
In this issue
Advertisement
W.S. Bartynski
Posterior Reversible Encephalopathy Syndrome, Part 2: Controversies Surrounding Pathophysiology of Vasogenic Edema
American Journal of Neuroradiology Jun 2008, 29 (6) 1043-1049; DOI: 10.3174/ajnr.A0929
0 Responses
Jump to section
Related Articles
- No related articles found.
Cited By...
- Undiagnosed fibromuscular dysplasia in a deceased donor kidney transplant successfully treated with angioplasty
- Posterior reversible encephalopathy syndrome (PRES): presentation, diagnosis and treatment
- Posterior reversible encephalopathy syndrome
- Posterior reversible encephalopathy syndrome associated with the use of chemotherapeutic agents: a rare complication after treatment with vinorelbine
- Delayed Leukoencephalopathy: A Rare Complication after Coiling of Cerebral Aneurysms
- Intra-Arterial Verapamil Treatment in Oral Therapy-Refractory Reversible Cerebral Vasoconstriction Syndrome
- Tumour-like presentation of atypical posterior reversible encephalopathy syndrome with prominent brainstem involvement
- Posterior reversible encephalopathy syndrome in an HIV-infected patient on antiretroviral treatment: what is the risk factor?
- Controversy of posterior reversible encephalopathy syndrome: what have we learnt in the last 20 years?
- Reversible brain lesion following growth hormone replacement therapy in an adolescent
- Oxaliplatin-induced posterior reversible encephalopathy syndrome (PRES)
- Clinical Reasoning: A young man with acute encephalopathy, loss of vision, and upper motor neuron signs
- Clinical outcomes and risk factors for posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a multicentric case-control study
- Posterior Reversible Encephalopathy Syndrome as an Overlooked Complication of Induced Hypertension for Cerebral Vasospasm: Systematic Review and Illustrative Case
- Cytotoxic Edema in Posterior Reversible Encephalopathy Syndrome: Correlation of MRI Features with Serum Albumin Levels
- Posterior reversible encephalopathy syndrome is not associated with mutations in aquaporin-4
- Posterior Reversible Encephalopathy Syndrome in Patients With Cancer
- What to see when you are looking at confusion: a review of the neuroimaging of acute encephalopathy
- Hypertensive crisis: Reversible edema in leukoencephalopathy, retinopathy, now myelopathy?
- Sinking skin flap syndrome in glioblastoma
- Posterior reversible encephalopathy syndrome (PRES) in a patient with late postpartum eclampsia
- Clinicopathologic and MRI Characteristics of Presumptive Hypertensive Encephalopathy in Two Cats and Two Dogs
- Cerebral hyperperfusion syndrome: A novel presentation of internal carotid artery dissection
- An Updated Definition of Stroke for the 21st Century: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association
- Posterior reversible encephalopathy syndrome after bevacizumab therapy in a normotensive patient
- The many faces of posterior reversible encephalopathy syndrome
- Posterior Reversible Encephalopathy Syndrome: A Truly Treatable Neurologic Illness
- Posterior reversible encephalopathy syndrome: the importance of early diagnosis
- Posterior reversible encephalopathy syndrome mimicking a cerebral tumour
- The posterior reversible encephalopathy syndrome in HIV infection
- Detection of Microhemorrhage in Posterior Reversible Encephalopathy Syndrome Using Susceptibility-Weighted Imaging
- Dr. Varaprasad and Dr. Agrawal reply
- Reversible Posterior Leukoencephalopathy in a Venomous Snake (Bothrops asper) Bite Victim
- Unusual Adverse Event With Vandetanib in Metastatic Medullary Thyroid Cancer
- Dr. Varaprasad and Dr. Agrawal reply
- Posterior Reversible Encephalopathy Syndrome in Systemic Lupus Erythematosus
- Posterior Reversible Encephalopathy Syndrome: Increasing Recognition of an Important Clinical Entity in Young Patients with Systemic Lupus Erythematosus
- Suspicious Neuroimaging Pattern of Thrombotic Microangiopathy
- Type of Edema in Posterior Reversible Encephalopathy Syndrome Depends on Serum Albumin Levels: An MR Imaging Study in 28 Patients
- Phase I Study of Vandetanib During and After Radiotherapy in Children With Diffuse Intrinsic Pontine Glioma
- Cerebral vasomotor reactivity monitoring in posterior reversible encephalopathy syndrome
- Influenza A Encephalopathy, Cerebral Vasculopathy, and Posterior Reversible Encephalopathy Syndrome: Combined Occurrence in a 3-Year-Old Child
- Isolated Acute Nontraumatic Cortical Subarachnoid Hemorrhage
- ENCEPHALITIS DURING INTERFERON BETA-1A TREATMENT IN A CHILD WITH OPTIC NEURITIS
- ASYMPTOMATIC SPINAL CORD INVOLVEMENT IN POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME
- Reversible cerebral vasoconstriction syndrome
- Hemorrhage in Posterior Reversible Encephalopathy Syndrome: Imaging and Clinical Features
- Reversible posterior leukoencephalopathy syndrome caused by hanging
- MR Imaging Findings of Medulla Oblongata Involvement in Posterior Reversible Encephalopathy Syndrome Secondary to Hypertension
- Reversible Encephalopathy after Cardiac Transplantation: Histologic Evidence of Endothelial Activation, T-Cell Specific Trafficking, and Vascular Endothelial Growth Factor Expression
This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.
More in this TOC Section
Similar Articles
Advertisement